Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

RAFIK GHOBRIAL

Allopathic & Osteopathic Physicians Transplant Surgery

NPI
1326072604
CMS profile
14375
Location
HOUSTON, TX

General Payments · PY2019–2025

$143,723.56

  • Reported across 273 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$13,036.50

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $12,250.00 5
Food and Beverage $786.50 31

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,739.60 75
PY2020 $583.16 25
PY2021 $1,756.99 20
PY2022 $9,498.94 29
PY2023 $51,028.58 48
PY2024 $66,079.79 40
PY2025 $13,036.50 36

Payment records · PY2025 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $15.57 11/17/2025 Food and Beverage Undisputed 06/30/2026 1202935910 CMS
AstraZeneca Pharmaceuticals LP $19.75 02/19/2025 Food and Beverage Undisputed 06/30/2026 1206167386 CMS
AstraZeneca Pharmaceuticals LP $17.85 08/11/2025 Food and Beverage Undisputed 06/30/2026 1206737348 CMS
Baxter Healthcare $42.81 03/17/2025 Food and Beverage Undisputed 06/30/2026 1181701663 CMS
Eisai Inc. $27.95 09/29/2025 Food and Beverage Undisputed 06/30/2026 1244506203 CMS
GENZYME CORPORATION $4,375.00 01/24/2025 Consulting Fee Undisputed 06/30/2026 1233250296 CMS
Gilead Sciences, Inc. $22.60 02/20/2025 Food and Beverage Undisputed 06/30/2026 1234498796 CMS
Gilead Sciences, Inc. $21.52 04/17/2025 Food and Beverage Undisputed 06/30/2026 1234510203 CMS
Gilead Sciences, Inc. $22.03 05/12/2025 Food and Beverage Undisputed 06/30/2026 1234504845 CMS
Gilead Sciences, Inc. $22.69 06/12/2025 Food and Beverage Undisputed 06/30/2026 1234497936 CMS
Gilead Sciences, Inc. $22.76 07/24/2025 Food and Beverage Undisputed 06/30/2026 1234497048 CMS
Gilead Sciences, Inc. $21.73 08/21/2025 Food and Beverage Undisputed 06/30/2026 1234508125 CMS
Gilead Sciences, Inc. $22.61 09/18/2025 Food and Beverage Undisputed 06/30/2026 1234498688 CMS
Gilead Sciences, Inc. $9.43 10/17/2025 Food and Beverage Undisputed 06/30/2026 1234588004 CMS
Gilead Sciences, Inc. $22.41 10/23/2025 Food and Beverage Undisputed 06/30/2026 1234500761 CMS
Gilead Sciences, Inc. $21.85 12/01/2025 Food and Beverage Undisputed 06/30/2026 1234506935 CMS
Gilead Sciences, Inc. $28.92 12/18/2025 Food and Beverage Undisputed 06/30/2026 1234445155 CMS
Intercept Pharmaceuticals, Inc. $16.49 04/07/2025 Food and Beverage Undisputed 06/30/2026 1249875956 CMS
Intercept Pharmaceuticals, Inc. $21.43 05/05/2025 Food and Beverage Undisputed 06/30/2026 1249875958 CMS
Madrigal Pharmaceuticals $15.88 02/13/2025 Food and Beverage Undisputed 06/30/2026 1248262915 CMS
Madrigal Pharmaceuticals $15.17 03/20/2025 Food and Beverage Undisputed 06/30/2026 1248262917 CMS
Madrigal Pharmaceuticals $16.27 06/19/2025 Food and Beverage Undisputed 06/30/2026 1248262919 CMS
Madrigal Pharmaceuticals $16.62 08/07/2025 Food and Beverage Undisputed 06/30/2026 1248262921 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.10 05/19/2025 Food and Beverage Undisputed 06/30/2026 1231984467 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.73 12/09/2025 Food and Beverage Undisputed 06/30/2026 1231984469 CMS
SANOFI US SERVICES INC. $1,750.00 04/04/2025 Consulting Fee Undisputed 06/30/2026 1233250388 CMS
SANOFI US SERVICES INC. $875.00 04/04/2025 Consulting Fee Undisputed 06/30/2026 1233250390 CMS
SANOFI-AVENTIS U.S. LLC $4,375.00 01/24/2025 Consulting Fee Undisputed 06/30/2026 1233250270 CMS
SANOFI-AVENTIS U.S. LLC $875.00 02/27/2025 Consulting Fee Undisputed 06/30/2026 1233250276 CMS
SANOFI-AVENTIS U.S. LLC $59.07 05/16/2025 Food and Beverage Undisputed 06/30/2026 1233250318 CMS
Surgical Specialties Corporation (us), Inc. (dba Corza Medical) $105.66 09/10/2025 Food and Beverage Undisputed 06/30/2026 1229344994 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.87 02/10/2025 Food and Beverage Undisputed 06/30/2026 1223824846 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.08 03/24/2025 Food and Beverage Undisputed 06/30/2026 1223857985 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.74 05/28/2025 Food and Beverage Undisputed 06/30/2026 1223932356 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.84 06/30/2025 Food and Beverage Undisputed 06/30/2026 1223880409 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.07 08/25/2025 Food and Beverage Undisputed 06/30/2026 1223908361 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.